Nuplazid
Total Payments
$103,852
Transactions
24
Doctors
7
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $1,950 | 2 | 2 |
| 2020 | $1,500 | 1 | 1 |
| 2019 | $45,838 | 3 | 0 |
| 2018 | $29,171 | 11 | 0 |
| 2017 | $25,393 | 7 | 4 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $79,633 | 15 | 76.7% |
| Consulting Fee | $21,377 | 6 | 20.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,950 | 2 | 1.9% |
| Travel and Lodging | $892.00 | 1 | 0.9% |
Payments by Type
Research
$79,633
15 transactions
General
$24,219
9 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ACP-103-055 | ACADIA Pharmaceuticals Inc | $45,838 | 0 |
| ACP-103-038 | ACADIA Pharmaceuticals Inc | $29,171 | 0 |
| ACP-103-015 | ACADIA Pharmaceuticals Inc | $4,624 | 1 |
Top Doctors Receiving Payments for Nuplazid
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Kansas City, KS | $75,009 | 14 |
| , MD | Clinical Neurophysiology | Phoenix, AZ | $11,000 | 2 |
| , MD | Specialist | Carlsbad, CA | $6,892 | 2 |
| , MD | Behavioral Neurology & Neuropsychiatry | Saint Louis, MO | $4,624 | 1 |
| , MD | Neurology | Los Angeles, CA | $2,877 | 2 |
| , MD | Geriatric Psychiatry | Providence, RI | $1,500 | 1 |
| , MD | Psychiatry | Boston, MA | $1,500 | 1 |
| , M.D | Psychiatry | Irvine, CA | $450.00 | 1 |
Ad
Manufacturing Companies
- ACADIA Pharmaceuticals Inc $103,852
Product Information
- Type Drug
- Total Payments $103,852
- Total Doctors 7
- Transactions 24
About Nuplazid
Nuplazid is a drug associated with $103,852 in payments to 7 healthcare providers, recorded across 24 transactions in the CMS Open Payments database. The primary manufacturer is ACADIA Pharmaceuticals Inc.
Payment data is available from 2017 to 2021. In 2021, $1,950 was paid across 2 transactions to 2 doctors.
The most common payment nature for Nuplazid is "Unspecified" ($79,633, 76.7% of total).
Nuplazid is associated with 3 research studies, including "ACP-103-055" ($45,838).